The stepwise tumor immunity events are eventually executed through CD8+ T cell‐directed tumor cytolysis, targeting cancer cells by granule exocytosis and Fas ligand (Fas L)‐mediated apoptosis as well as IFN‐γ or TNFα -induced cytotoxicity (44). The gene discussed is CD8A; the disease is cancer.